We have a disease of obesities, Angela Fitch, chief medical officer at Knownwell, a national obesity-care clinic, and a former president of the Obesity Medicine Association, told me
[2] Additionally, GLP-1 agonists may be prescribed for individuals with type 2 diabetes who have coexisting conditions such as atherosclerosis, heart failure, or chronic kidney disease, as these medications have demonstrated potential benefits beyond glycemic control
Even temporary weight loss produces lasting health benefits including improved cardiovascular risk markers, reduced joint stress, improved sleep apnea, and better metabolic function
Local anesthesia , the donor and recipient areas are numbed
Each dose level in the titration protocol typically lasts 4 weeks before increasing